Low-dose naltrexone
Selected indexed studies
- Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization. (Med Sci (Basel), 2018) [PMID:30248938]
- Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review. (Curr Pain Headache Rep, 2020) [PMID:32845365]
- Low-Dose Naltrexone in Rheumatological Diseases. (Mediterr J Rheumatol, 2023) [PMID:37223594]
_Worker-drafted node — pending editorial review._
Connections
Low-dose naltrexone is a side effect of
Sources
- Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization. (2018) pubmed
- Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review. (2020) pubmed
- Low-Dose Naltrexone in Rheumatological Diseases. (2023) pubmed
- Low-dose Naltrexone Improves post-COVID-19 condition Symptoms. (2024) pubmed
- Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy. (2018) pubmed
- The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review. (2023) pubmed
- The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. (2014) pubmed
- Therapeutic Uses and Efficacy of Low-Dose Naltrexone: A Scoping Review. (2025) pubmed
- Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy. (2024) pubmed
- The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders. (2018) pubmed